Which has the lower trailing P/E, BMY or MDT?

BMY has the lower trailing P/E: BMY trades at 17.57 and MDT at 22.58. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or MDT?

Over the past five years, MDT grew revenue faster — BMY at a 2.52% CAGR versus MDT at 5.18%.

Does BMY or MDT pay a bigger dividend?

BMY yields 4.00% and MDT yields 3.38% based on trailing dividends and the latest price.

Is BMY or MDT more profitable?

BMY runs the higher net margin — BMY at 15.01% versus MDT at 13.20%.

How have BMY and MDT total returns compared?

Over the past 10 years, BMY delivered 2.02% and MDT delivered 2.30% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Medtronic plc (MDT)

A side-by-side comparison of Bristol-Myers Squibb Company and Medtronic plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$129.88B

$63.60HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

MDT

Medtronic plc

$111.21B

$86.88HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — BMY vs MDT

growth of $100 · dividends reinvested · last 30y

BMY +735.9%MDT +1080.2%MDT compounded faster

BMY MDT

BMY vs MDT: by the numbers

•BMY is the larger company ($129.88B vs $111.21B market cap).
•BMY trades at the lower trailing earnings multiple (17.57 vs 22.58 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (15.01% vs 13.20% net margin).
•MDT grew revenue faster over the past five years (5.18% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.00% vs 3.38%).

Metrics side by side

Valuation

Metric	BMY	MDT
P/E ratio	17.57	22.58
Forward P/E	9.86	15.26
P/S ratio	2.64	2.98
P/B ratio	6.37	2.19
PEG ratio	1.87	6.72
EV / EBITDA	10.34	14.41
FCF yield	9.31%	5.00%

Profitability

Metric	BMY	MDT
Gross margin	68.75%	65.02%
Operating margin	25.67%	17.78%
Net margin	15.01%	13.20%
ROE	36.25%	9.70%
ROIC	13.90%	6.13%

Dividends

Metric	BMY	MDT
Dividend yield	4.00%	3.38%
Payout ratio	72.25%	76.00%

Growth (annualized)

Metric	BMY	MDT
Revenue CAGR (5Y)	2.52%	5.18%
EPS CAGR (5Y)	9.38%	0.83%
FCF CAGR (5Y)	-2.50%	3.07%
Total return CAGR (5Y)	2.73%	-5.43%

Frequently asked

Which has the lower trailing P/E, BMY or MDT?: BMY has the lower trailing P/E: BMY trades at 17.57 and MDT at 22.58. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or MDT?: Over the past five years, MDT grew revenue faster — BMY at a 2.52% CAGR versus MDT at 5.18%.
Does BMY or MDT pay a bigger dividend?: BMY yields 4.00% and MDT yields 3.38% based on trailing dividends and the latest price.
Is BMY or MDT more profitable?: BMY runs the higher net margin — BMY at 15.01% versus MDT at 13.20%.
How have BMY and MDT total returns compared?: Over the past 10 years, BMY delivered 2.02% and MDT delivered 2.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full MDT analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Medtronic P/E ratio Bristol-Myers Squibb dividend yield Medtronic dividend yield Bristol-Myers Squibb ROE Medtronic ROE Bristol-Myers Squibb operating margin Medtronic operating margin Bristol-Myers Squibb revenue growth Medtronic revenue growth Bristol-Myers Squibb free cash flow Medtronic free cash flow

Bristol-Myers Squibb & Medtronic appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.